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Importance and Objective: Physical function limitations affect approximately one 
fifth of middle-aged women. However, correlates of these limitations are poorly 
understood; limited research investigates the associations between menopausal status, 
physical function, physical activity, and body composition, and the research available 
is equivocal about these associations. Methods: Using a cross-sectional approach, 107 
(53.31 ± 6.14 yr) middle-aged women completed six objective assessments of physical 
function (transfer task, 8-foot up-and-go, 30-second chair stands, 6-minute walk test, 
lift and carry, and lower extremity physical function composite score) and one 
subjective assessment of physical function (36-Item Short Form Survey physical 
functioning subscale). Muscular strength was measured using handgrip dynamometry. 
Physical activity (average steps per day, average minutes of moderate plus vigorous 
physical activity per day, and average minutes of total physical activity per day) was 
measured via accelerometry. Body composition (percent fat and percent mineral-free 
lean mass) was measured with Dual Energy X-Ray Absorptiometry. Women self-
identified menopausal status (premenopausal, perimenopausal, and postmenopausal). 
Discussion: Age was significantly different between menopausal status groups 
(p<0.05). When controlling for age and number of chronic medical conditions, no 
significant differences between menopausal status groups were found for any 
outcomes (all p>0.05). In a multiple linear regression controlling for number of 
chronic medical conditions, menopausal status was not significantly associated with 
any outcome (all p>0.05). However, age was independently associated with two 
 
 
outcomes: (1) transfer task time (p=0.015), explaining 11.1% of observed variability, 
and (2) handgrip strength (p=0.002), explaining 14.7% of observed variability.  
Conclusion: Middle-aged women, regardless of menopausal status, have similar body 
composition, physical activity levels, and physical function ability. 
Key Words: Menopausal status – Middle-age – Physical function – Physical activity – 
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A major health concern associated with aging is physical function 
performance. Physical function performance, often referred to as “functional ability” 
or simply “physical function”, is an individual’s ability to perform basic actions 
involving strength, mobility, and endurance that are essential for maintaining 
independence and carrying out more complex activities (1).  
Physical function is not only an issue impacting older adults (those ≥65 years 
of age): there is evidence that men and women experience declines in physical 
function during middle-age (approximately ages 40-64). An estimated 18-22% of this 
population has significant physical function limitations (2,3), with a higher percentage 
of women experiencing limitations compared to age-matched men (2). Recent 
evidence suggests that these physical function limitations are associated with health 
issues earlier in life than previously thought; a study of 45-year-old men and women 
showed that slower gait speed (a measure of physical function) is associated with 
markers of poorer cognitive health (such as lower IQ and smaller brain volume), as 
well as accelerated biological aging across multiple organ systems (4). Therefore, it is 
important to assess for and treat physical function limitations that might occur in 
middle-age (5).   
Resolving any issues in physical function during middle-age may be important 
for preserving physical function in older adulthood (6). While adequate physical 




Physical function is a significant determinant of their ability to “age in place”, or to 
continue to live independently despite health issues often associated with advancing 
age (7). Previous studies in older adults show that age, physical activity, and body 
composition are associated with physical function performance (8,9). Further, with 
increased age, older adults experience a decline in physical activity level (10), an 
increase in adipose tissue (11), a decrease in lean mass (11), and a decline in 
functional ability (9). These age-related changes tend to be more pronounced in 
women, with more women than men experiencing physical function limitations (12). 
This gender gap may be due to older women tending to have lower physical activity 
levels (12) and higher prevalence of depressive symptoms (12), arthritis (13), and 
obesity (13) compared to age-matched men. 
In addition to physical function, many other aspects of health seem to decline 
in middle-age. For example, during middle-age in both genders, age has a positive 
linear association with number of total health deficits including long-term disability 
and arthritis (14). Additional health changes in middle-aged women are associated 
with menopause, which typically begins when a woman is in the mid-40s, and is 
marked by the permanent cessation of menstruation due to loss of ovarian follicular 
activity (15). Menopause is driven by hormonal changes such as decreased estradiol 
(E2) and increased follicle stimulating hormone (FSH) and is associated with health 
issues including fatigue, anxiety, depression, dips in cognitive performance, loss of 
bone mineral density, increases in body fat, lower physical activity levels, and worse 
physical function (5). Menopausal status has many categorizations but can be most 




measures of menopausal status are self-report measures, which ask women about the 
frequency and regularity of their menstrual period. This study utilized the Study of 
Women’s Health Across the Nation (SWAN) criteria, a frequently used self-report 
definition of menopausal stages. 
Despite the number of health changes associated with middle-age in women, 
research in this population is limited for a number of reasons. Middle-aged women 
experience hormonal fluctuations in both the short term (days to weeks) due to 
menstrual cycles, and in the long term (months to years) due to menopause (5). There 
are indications that these hormonal fluctuations are correlated with body composition, 
physical activity, physical function, and other variables studied in the field of exercise 
science (16), possibly explaining why males account for 61% of subjects in exercise 
science research (17). Furthermore, middle-aged women have a high potential for 
pregnancy, which can make it possibly unsafe for subjects to perform certain 
procedures, including Dual Energy X-Ray Absorptiometry (DXA) assessments of 
body composition (18). Pregnancy can also impact physical activity levels and 
physical function (19), making pregnant women not representative of the overall 
population of middle-aged women. Finally, researchers often have difficulty sampling 
middle-aged adults due to time constraints including juggling work with caregiving for 
children or elderly parents (6). Conversely, young adults are easy to recruit from 
universities, and older adults are easy to recruit through senior housing, senior 
organizations, or healthcare providers’ offices. 
Despite the low volume of research in middle-aged women, research 




example, the associations between age and physical function, physical activity, and 
body composition in this population have been investigated (9,10,20–23). The 
majority of research suggests that, with increased age, middle-aged women experience 
decreased physical function (9,20), decreased physical activity (21), increased 
sedentary time (10), and increased subcutaneous and visceral abdominal fat (22,23).  
Associations between menopausal status and physical function, physical 
activity, and body composition are less clear, due to lack of research and measurement 
technique standardization. There are preliminary indications that reduced physical 
function is associated with menopausal status. Specifically, when controlling for age 
and a variety of other potential covariates in middle-aged women, self-reported 
menopausal status is associated with the objective physical function measures of 3 
stair ascent time (24), sit-to-stand time (24), and maximal gait velocity (24) as well as 
the strength outcome of handgrip strength (25–27) and the self-report physical 
functioning outcome of the 36-Item Short Form Survey (SF-36) physical functioning 
subscale (24,28,29). However, there are conflicting results, showing that when 
controlling for age, there are no significant associations between self-report 
menopausal status and the physical function measures of natural gait velocity (26,28), 
single-leg stand time (25), and repeated chair stands (25,26). Furthermore, when 
controlling for age, menopausal status measured using hormonal methods was 
associated with handgrip strength, but not associated with maximal gait velocity and 
6-minute walk test performance (16). 
There are also indications that negative changes in body composition like 




lean mass (31) are associated with menopausal status when controlling for age. 
However, most research using body mass index (BMI) as a body composition estimate 
has found no associations with menopausal status when controlling for age (32,33). 
Finally, there are preliminary indications that, even when controlling for age, 
the menopausal transition is associated with reduced physical activity levels when 
using accelerometry (34). However, other studies have found no association between 
menopausal status and physical activity that has been self-reported (16,26). 
Overall, the findings regarding the associations between menopausal status and 
physical function, physical activity, and body composition are often inconsistent in 
their methods and results. Thus, the differences in age, physical function ability, 
physical activity levels, and body composition among premenopausal, 
perimenopausal, and postmenopausal women are not well characterized. Furthermore, 
it is not known to what degree changes in physical function and the associated 
variables of physical activity and body composition observed during middle-age are 
related to menopausal status versus chronological age. Therefore, more research is 
needed to clarify the relationships between menopausal status and physical function, 
physical activity, and body composition in middle-aged women. 
 Thus, the primary aim of this study is to describe the differences in age, 
physical function performance, physical activity, and body composition among 
premenopausal, perimenopausal, and postmenopausal women. The primary hypothesis 
is that there will be significant differences in age, physical function, physical activity, 
and body composition among the three menopausal groups. Specifically, physical 




progress through the menopausal transition, whereas age and fat mass will increase as 
women progress through the menopausal transition. 
The secondary aim of this study is to examine the strength of the independent 
associations between menopausal status and chronological age and physical function 
performance, physical activity, and body composition in middle-aged women. It is 
hypothesized that compared to chronological age, menopausal status will be more 
highly associated with physical function performance, physical activity, and body 
composition in middle-aged women.  
Through these aims, this study will build on the existing literature by adding 
measures of physical function that have been previously unstudied in relation to 
menopausal status (transfer task, 8-foot up-and-go, 30-second chair stands, and lift-
and-carry), as well as previously studied measures (6-minute walk test, handgrip 
strength, and the SF-36 physical functioning subscale) in order to provide a 
comparison with existing research.  Further, it will add to the single study comparing 
accelerometer-measured physical activity between menopausal groups (34) and will 
help clarify differences in BMI, fat mass, and lean mass that have exhibited little 
agreement in previous studies (22,30–33,35–41). Finally, by examining the 
associations between age and menopausal status with physical function, physical 
activity, and body composition, this study will help clarify the potential contributors to 






REVIEW OF LITERATURE 
 
Introduction: 
  Advanced age is associated with many health issues including decreased 
physical function, decreased physical activity, and poorer body composition; while 
these are often seen as issues only impacting older adults (those 65 and older), middle-
age (ages 40-64) may actually be the time in which these factors begin to worsen 
(2,3,10,20–22,35). Therefore, middle-age may offer an opportunity to prevent or delay 
detrimental changes in health (6). Middle-age is also a unique physiological time for 
women as this is when menopause occurs, which, in addition to age, also seems to 
negatively impact health in many ways, ranging from increased anxiety, depression, 
fatigue, and lean mass to decreased physical activity, physical function, and fat mass 
(5). Despite the potential for middle-age to be an optimal time to promote healthy 
behaviors in women before they worsen during older adulthood (6), women are 
understudied in exercise science (17). Specifically, there are many gaps and little 
agreement in the literature regarding the associations between menopausal status and 
physical function (16,24–29), physical activity (16,26,34), and body composition 
(31,42,43) in middle-aged women. The following literature review explores the 
existing evidence regarding the relationships between age, menopausal status, physical 





Defining Menopausal Status: 
Menopause is the permanent cessation of menstruation, resulting from the loss 
of ovarian follicular activity, typically beginning around age 45 (15). A variety of 
characteristic hormonal and physiological changes occur throughout the menopausal 
transition. Notably, El Khoudary et al. (5) performed a recent review of studies 
utilizing data from the longitudinal project, the Study of Women’s Health Across the 
Nation (SWAN), following middle-aged women to explore the relationship between 
menopause and many of its covariates, including hormonal change. They found that 
decreases in estradiol (E2) start approximately 2 years before the final menstrual 
period (FMP), and continue for two years afterwards (44). Further, follicle stimulating 
hormone (FSH) increases from approximately 7 to 2 years before the FMP, with these 
patterns in hormonal change stable across body composition, race, and age of FMP 
(44). Driven by these hormonal changes, menstrual cycle length increases over the 
course of the menopausal transition starting approximately 7.5 years before the FMP 
and accelerating around 4 years before the FMP, with different trends in menstrual 
cycle change seen in different races/ethnicities as well as in different ages of 
menopausal transition onset (45).  
Burger et al. (15) offers a more comprehensive exploration of the hormonal 
changes during menopause, finding a variety of other changes in addition to those 
discussed above (44,45). Using data from the Melbourne Women’s Midlife Health 
Project, another large longitudinal study following middle-aged women, Burger et al. 
found that an early hormonal signal of menopause is a decrease in inhibin B and anti-




as an increase in luteinizing hormone (LH) and the failure of LH to surge in response 
to estrogen, which would normally stimulate ovulation (15).  
Although age and menopausal status are related, there are a host of other 
factors associated with the timing of the menopausal transition besides chronological 
age. For example, when controlling for socioeconomic and health status, later age of 
the final menstrual period (FMP) is significantly associated with higher level of 
education, higher weight, past oral contraceptive use, present employment, not 
smoking, consuming alcohol less frequently, being less physically active, and having 
better self-reported health, although timing of the FMP is not associated with 
race/ethnicity (41). Furthermore, studies in Iran (46) and Finland (47) have found that 
mean age at menopause is increasing over time across the world. Specifically, for 
Iranian women born in the 1930’s, the mean age of menopause was 48.5, increasing to 
49.9 for women born in the 1950’s (46), and in Finland mean age at menopause was 
50 in 1997, increasing to 51 in 2007 (47). This indicates that the relationship between 
age and menopausal status is changing over time, and therefore age is not a standalone 
predictor of menopausal status and its correlates such as physical function. 
 Hormonal changes drive a variety of symptoms during the menopausal 
transition, which can also impact physical function (48). Lovejoy et al. (2008) found 
that the menopausal transition is associated with negative metabolic changes as it 
progresses (22). Specifically, when following premenopausal women for 4 years and 
comparing those who remained premenopausal at follow-up with those who became 
postmenopausal, both groups experienced decreased energy expenditure during 




sleep (sleeping energy expenditure); however, these decreases were larger in those that 
became postmenopausal (9.3% decrease in daily energy expenditure compared to a 
7% decrease in those that remained premenopausal, and a 7.9% decrease in sleeping 
energy expenditure compared to a 5.3% decreases in those that remained 
premenopausal), although differences were not significant (p>0.05). Additionally, 
there was a significant decrease in fat oxidation (32.4%, p<0.05) in women who were 
postmenopausal at follow up, but no significant change (9.8% decrease, p>0.05) in 
those remaining premenopausal.  
Vasomotor symptoms (hot flashes and night sweats) are also a common 
symptom during menopause. Vasomotor symptoms were reported by 80% of SWAN 
participants (49). This number is impacted by race and ethnicity as well as 
socioeconomic status, as Black women report worse and more prevalent symptoms 
than White and Hispanic women, Asian women report the least symptoms, and 
women of lower socioeconomic status report worse and more symptoms regardless of 
race (49). Significant associations between the menopausal transition and increases in 
reported sleep difficulties, depressive symptoms, anxiety, poor cardiovascular health, 
decreased bone mineral density, and decreased sexual functioning have also been 
reported by studies examining SWAN data (5). 
 In addition to physiological factors, researchers have also found that the social 
determinants of health during menopause impact this transition in middle-aged women 
(50). Menopause and the loss of youth it signifies are generally seen as negative in 
western cultures, however, in other countries such as Iran and China, there are more 




improved quality of life during this transition (50). Notably, the severity of 
menopausal symptoms and quality of life during menopause can be impacted 
indirectly by cultural influences on diet, body composition, smoking, and exercise 
(50). Practicing a religion, increased social support, increased level of education, and 
being married are also associated with lower severity and improved perceptions of 
menopausal symptoms, underscoring the impact of women’s emotional and mental 
health on their physical health during middle-age (50). Importantly, menopausal 
symptoms such as depressive symptoms have been associated with poorer physical 
function in middle-aged women and therefore might account for some of the 
differences in physical function observed between menopausal status groups (28). 
Menopausal status has a variety of categorizations utilizing different phases 
and sub-phases. However, menopausal status is most simply divided into 
premenopausal, perimenopausal, and postmenopausal. Menopausal status can be 
assessed as a self-report bleeding measure as in this study, or via blood draws looking 
at FSH and other biomarkers (15). Self-report bleeding measures of menopausal status 
involve asking women about the frequency and regularity of their menstrual period. 
This study utilized the SWAN criteria, the most frequently used definition of 
menopausal stages in existing literature. Like the majority of preexisting literature, this 
study combined both perimenopausal stages (stages 2 and 3). The SWAN criteria is as 
follows: stage 1) premenopausal is defined as no change in menstrual bleeding 
patterns; stage 2) early transition/perimenopause is defined as a change in length of 
bleeding or the interbleed interval; stage 3) late transition/perimenopause is defined as 




postmenopause, which is divided into natural postmenopause, defined as amenorrhea 
for the past 12 months not due to hysterectomy (surgical removal of the uterus), and 
surgical postmenopause, defined as a bilateral oophorectomy (surgical removal of the 
ovary) with or without hysterectomy (5).  
An additional self-report measure of menopausal status is the Staging of 
Reproductive Aging Workshop (STRAW) criteria, born out of an expert consensus 
between researchers in predominant studies of menopause and clinicians (51). This 
criteria uses the same four stages as stated above for the SWAN criteria, with slightly 
different definitions: premenopause is defined as regular menstrual cycles with no 
change in cycle length, early transition is defined as a persistent difference of seven or 
more days in consecutive menstrual cycle, late transition is defined as 2-11 months of 
amenorrhea, and postmenopause is defined again as no menstrual bleeding for 12 or 
more months. 
Gracia et al. (52) created the PENN-5 criteria, a third definition of menopausal 
status based on self-reported menstrual bleeding. This criteria adds a fifth stage (late 
premenopause) to attempt to define more subtle changes seen at the start of 
menopause. This definition states that premenopause involves regular menstrual 
cycles with no change in cycle length, late premenopause involves a persistent 
difference of seven or more days in consecutive menstrual cycle, early transition 
involves at least two cycle length changes of at least 7 days, late transition involves 3-
11 months of amenorrhea, and postmenopause involves at least 12 months of 
amenorrhea. This study also found that the new stage of “late premenopause” was 




suggesting that significant hormonal changes occur early in the menopausal transition, 
even with very minor changes in cycle length. 
Menopausal status can also be defined using hormonal levels, which requires a 
more invasive approach. A popular method for this involves using an algorithm from 
the Women’s Ischemia Syndrome Evaluation (WISE) study, which uses fasting blood 
draw measures of E2 and FSH as well as time since last menstrual period (LMP), age, 
and history of hysterectomy or oophorectomy in a complex algorithm to determine 
whether a woman is premenopausal, perimenopausal, or postmenopausal (53).  
There is little research into the agreement between self-report measures and 
hormonal measures of menopausal status. However, one study found 76.7% 
concordant classification between SWAN and WISE criteria when examining 3,000 
middle-aged women, and 72.7% concordant classification when looking at the same 
sample five years later (54). 
Overall, age is not a standalone predictor of menopausal status, as ANM is 
changing over time (46,47) and is associated with a variety of socioeconomic and 
physiologic conditions (41). Further, the symptoms associated with menopause are 
highly variable due to a variety of socioeconomic and physiologic influences (41), and 
these symptoms can influence physical function (48). Therefore, it may be prudent to 
compare the differential impact of menopause and chronological age on indicators of 
health in middle-aged women, such as physical function performance, physical 






Physical Function Performance in Middle-Age: Relationships with Age 
 Physical function is an individual’s ability to perform basic actions involving 
strength, mobility, and endurance that are essential for maintaining independence and 
carrying out more complex activities (1). Adequate physical function ability is often 
perceived as only important for older adults, however many middle-aged adults 
experience limitations in physical function (2,3), emphasizing a need to examine these 
outcomes across the lifespan. It is also important to note that there may be small but 
statistically significant sex differences in physical functional ability across middle and 
older age. For example, Gardener et al. (2) surveyed a sample of 11,216 middle-aged 
(50-64) British adults and found that 19% of women self-reported a functional 
limitation in mobility (walking), in this case difficulty walking a quarter of a mile, 
compared to 18% of men of the same age.  
Similarly, Brown et al. (3) found evidence of physical function limitations in 
middle-age, with 22% of 6,874 subjects aged 50-64 developing self-reported 
limitations in activities of daily living (ADLs), a measure of physical function. The 
most common ADL impairment reported was difficulty dressing (14%). This study 
demonstrated the potential for these functional declines to accelerate with age, but also 
highlighted the potential for reversing these declines; when a 2 year follow-up was 
performed after subjects initially reported ADL impairment, 4% had died, 9% 
experienced additional ADL decline, and 50% had sustained ADL impairment, but 
37% were able to recover functional abilities. Similar patterns were observed with 




Most recently, Hartmann Rasmussen et al. (4) suggests that physical function 
may impact health even at the very beginning of middle-age; a study of 904 45-year-
old men and women showed that slower gait speed during a 6-meter walk (a measure 
of physical function) is associated with markers of poorer cognitive health (such as 
lower IQ [β 0.23, p<0.001] and smaller brain volume [β 0.10, p=0.02]), in addition to 
accelerated biological aging across multiple organ systems (β -0.27, p<0.001). This 
indicates that interventions to improve physical function in middle-age may offer both 
immediate and long-term benefits.  
 In older adults, it is well established that physical function declines, and that 
this decline is more pronounced in women than in men (55,56). A survey of nearly 
2,000 men and women ages 65 to 74 in five sites across the globe assessed self-
reported mobility difficulty (difficulty walking 400m or climbing stairs), self-reported 
ADL disability (difficulty performing at least one ADL), and the short physical 
performance battery (SPPB), a set of physical function tasks (12). In four out of five 
sites, women had significantly higher incidence of mobility difficulties and ADL 
disabilities, and performed significantly worse on the SPPB compared to men (p<0.05 
for all) (12). Even after controlling for age, chronic diseases, education, sufficiency of 
income, and depressive symptoms, the differences between male and female results 
remained significant for mobility difficulties. 
 Leigh et al. (9) examined longitudinal self-report physical function data for 
over 4,500 women and found four distinct patterns for change in physical function 
with age in older women (73-90). Physical function was assessed using the self-report 




physical function worsening further over time, to high initial physical functioning 
worsening slightly over time. Self-reported exercise level was the strongest predictor 
of physical function groups (odds ratio for “high” exercisers being in the lowest 
physical function group compared to the highest was 0.04). All four of these physical 
function groups experienced significant declines in physical function with time, 
demonstrating the adverse impact of age on physical function. 
 In middle-aged women, Ward-Ritacco et al. (20) explored the relationship 
between physical function and age. In 64 postmenopausal women ages 45 to 65, age 
was a significant independent predictor of both 8-foot up-and-go (F=3.47, p=0.009) 
and 30-second chair stand (F=4.95, p=0.001), but not 6-minute walk test performance 
(p>0.05). Other significant predictors of the 8-foot up-and-go were muscle quality and 
leg power, whereas other significant predictors of the 30-second chair stand were 
muscle quality and leg strength. Significant predictors of the 6-minute walk test 
included muscle quality, leg strength, total number of medical conditions, steps per 
day, and adiposity. 
It is clear that declines in physical function impact older adults, however recent 
research suggests that around one fifth of middle-aged adults are also impacted (2,3). 
There is a decline in physical function seen with age, including throughout middle-age 
(9,10,20), and there is evidence that this decline is associated with poorer health (4). 
Therefore, there is a need to better understand the correlates of physical function in 
middle-aged women, enabling healthcare professionals to improve physical function 




Objectively Measured Physical Function Performance in Middle-Age: 
Relationships with Menopausal Status 
 While physical function clearly declines with age, it is less clear to what 
degree physical function changes are associated with menopausal status. Additionally, 
it is not well understood which measures of physical function have an association with 
which measures of menopausal status. Establishing these associations may provide 
insight into the causes of decreased physical function often observed during middle-
age in women. Several studies have investigated the associations between menopausal 
status and objective measures of physical function (16,24–27), with all studies finding 
at least one significant association between menopausal status and a measure of 
physical function (most frequently handgrip strength) when controlling for age. 
Cooper et al. (25) examined the associations between self-reported menopausal status 
and timing of hysterectomy (surgical menopause) with muscular strength (handgrip 
strength), balance (single-leg stance time with eyes closed) and physical function 
(time to complete 10 chair stands) in 1,386 53-year-old British women who were not 
undergoing hormone replacement therapy (HRT). They found that postmenopausal 
women had weaker handgrip strength than premenopausal and perimenopausal women 
(p=0.07), although this difference was not statistically significant, even when 
accounting for body size (p=0.12). For those who underwent surgical menopause, 
lower age at hysterectomy was significantly associated with lower grip strength 
(p<0.05), even after adjustment for covariates including height and weight at age 53, 
father’s occupational class, head of household occupational class, cognitive function at 




significant associations between either menopausal status or timing of hysterectomy 
and chair rise or standing balance time (p>0.05).  
 Similarly, Da Câmara et al. (26) explored the relationship between menopausal 
status and physical function in 389 Brazilian women ages 40 to 65 years. Menopausal 
status was self-reported according to the STRAW criteria. Muscular strength 
(handgrip strength) and physical function (a 4-meter walk at the subject’s natural pace 
and time to complete 5 chair stands) were objectively measured. When adjusting for 
age, premenopausal women had higher handgrip strength (p=0.036) and faster chair 
stand times (p=0.29) compared to perimenopausal and postmenopausal women, but 
there were no statistically significant differences in gait speed between groups 
(p=0.91). However, once additional covariates (socioeconomic status, BMI, walking 
time per week, sitting time per week, reproductive history, and hypertension) were 
included, only the difference in grip strength remained significant, with 
premenopausal women having significantly higher grip strength than postmenopausal 
women (p=0.019). 
 Kurina et al. (27) examined 564 SWAN study participants ages 42-52 at 
enrollment and at a 3-year follow-up. Menopausal status was defined according to the 
SWAN criteria. Outcome measures were handgrip strength and pinch strength. 
Statistical analysis adjusted for age, BMI, income, smoking status, and physical 
activity level. Compared to women who remained premenopausal at follow-up, 
women who became postmenopausal by follow-up showed a 1.04 kg decline in grip 
strength (although this was not statistically significant, at p=0.10) and a 0.57 kg 




showed a 0.20 kg decline in pinch strength (p=0.04), and women who transitioned to 
late perimenopause showed a 0.93 kg decline in grip strength (although this was not 
statistically significant, at p=0.07).  
The Estrogenic Regulation of Muscle Apoptosis (ERMA) study by Bondarev 
et al. (16) used a cross-sectional design to further investigate associations between 
physical function and menopausal status in 903 Finnish women ages 47 to 55. Unlike 
the previous studies, menopausal status was determined with the use of fasting serum 
samples of FSH levels, in combination with self-reported menstrual cycle regularity 
according to the STRAW criteria. Handgrip strength and physical function (maximal 
walking speed over 10 meters and 6-minute walk test distance covered) were 
measured. After controlling for age, fat mass, height, physical activity, and education, 
the only significant association found between these variables was that 
postmenopausal women had lower handgrip strength (p<0.001) compared to 
premenopausal women. 
 As part of the Michigan Bone Health and Metabolism Study, Sowers and 
Tomey et al. (24) explored the relationship between physical function and menopausal 
status in 530 middle-aged women (mean age 44.8±4.8) as a part of a 5-year 
longitudinal study. Menopausal status was self-reported using the following stages: 
premenopausal (10 or more menstrual cycles in the past 12 months), perimenopausal 
(9 or less menstrual cycles in the past 12 months), and postmenopausal (no menstrual 
period in the last 12 or more months). Physical function measures included the SF-36 
physical functioning subscale, 40-foot brisk walk velocity, timed 3-stair ascent, and 




Controlling for age, BMI, and smoking status, women who underwent natural 
menopause had significantly poorer hand grip strength (p<0.0005), walk velocity 
(p<0.05), and SF-36 physical functioning scores (p<0.05) compared to women who 
were premenopausal and women who were perimenopausal at the 5-year follow-up. 
With the same control variables, women who underwent menopause surgically with 
hormone replacement or ovary conservation had significantly poorer walk velocity 
(p<0.05), SF-36 physical functioning scores (p<0.01), chair stand time (p<0.01), and 
stair ascent time (p<0.01) compared to premenopausal and perimenopausal women. 
Again with the same control variables, women who underwent menopause surgically 
without hormone replacement also had significantly poorer walk velocity (p<0.05), 
SF-36 physical functioning scores (p<0.01), chair stand time (p<0.01), and stair ascent 
time (p<0.01) compared to premenopausal and perimenopausal women. These 
findings indicate that, regardless of whether menopause occurs naturally or surgically 
and regardless of hormone replacement or ovary conservation, physical function tends 
to be worse in postmenopausal women compared to premenopausal and 
perimenopausal women. 
 The findings from these studies (16,24–27) indicate that perhaps muscular 
strength as measured by hand grip strength may be the first physiological factor to 
change as a result of menopause. This change in muscular capacity may occur first and 
over time, resulting in the changes in balance and physical function that are observed 
in some of these studies. The present study looks at handgrip strength and a variety of 




changes in handgrip strength occur in tandem with changes in physical function 
performance over the menopausal transition. 
Subjectively Measured Physical Function Performance in Middle-Age: 
Relationships with Menopausal Status 
 The present study also incorporates a subjective (self-reported) measure of 
physical function in order to compare results with objective measures of physical 
function. Several studies have explored only subjective measures of physical function 
and their association with menopausal status (28,29). In 2012, Tseng et al. performed a 
cross sectional analysis using data from the longitudinal SWAN study (28). 2,236 
women ages 45 to 57 self-reported menopausal status according to the SWAN criteria 
and completed the SF-36. Physical function limitation was defined as “substantial” 
(SF-36 physical functioning subscale scores of 50 or below), “moderate” (scores of 
51-85), and “none” (scores of 86-100). The association between menopausal status 
and self-reported physical function was assessed while controlling for age, ethnicity, 
research site, education, BMI, diabetes, hypertension, arthritis, depressive symptoms, 
smoking, and hormone use. Postmenopausal women were over three times more likely 
to have substantial functional limitations compared to premenopausal and 
perimenopausal women, regardless of whether menopause was natural (odds ratio = 
3.82, p<0.05) or surgical (odds ratio = 3.54, p<0.05). However, moderate limitations 
in physical function were not associated with menopausal status, as the odds ratio of 
moderate limitations compared to premenopausal and perimenopausal women was 





 In 2014, El Khoudary et al. (29) performed a longitudinal study that examined 
the associations between menopausal status and subjective physical function in 2,495 
women ages 45 to 57 years. Physical function limitations were defined as by Tseng et 
al. (“none”, “moderate”, and “substantial”, based on SF-36 physical functioning 
subscale scores) (28) and menopausal status was self-reported according to the SWAN 
criteria. This study had a median follow-up time of 9.7 years, and data was collected 
an average of 4.3 times per person. The study also assessed 24-hour fasting hormone 
levels, including serum testosterone (T), E2, and serum hormone-binding globulin 
(SHBG). Analyses were controlled for age, race, research site, economic status, 
comorbid conditions, final BMI, final physical activity level, and changes in BMI and 
physical activity. The odds of having a substantial functional limitation compared to 
having no or some limitation were significantly higher in late perimenopausal women, 
naturally postmenopausal women, surgically postmenopausal women, and hormone-
using/status unknown women compared to premenopausal and early perimenopausal 
women (all p<0.05). Further, lower E2 at visit 4 and less reduction in E2 and T from 
visit 4 to visit 12 were significantly associated with lower odds of reporting any 
functional limitations (p<0.05). Finally, a greater increase in SHBG from visit 4 to 
visit 12 was associated with greater odds of any functional limitations (p<0.05).  
 Based on this evidence (28,29), there seems to be a significant association 
between the SF-36 physical functioning subscale and menopausal status, with 
postmenopausal women self-reporting worse and more functional limitations 
compared to premenopausal and perimenopausal women, regardless of whether 




subjective and objective measurements of physical function in relationship to 
menopausal status, which is a gap in literature the present study addresses. 
Objectively Measured Physical Function Performance in Middle-Age: 
Relationships with Age at Menopause 
Beyond being associated with menopausal status, it is possible that physical 
function is associated with age at menopause. It is important to understand this 
association, as it may influence the associations between menopausal status and 
physical function. There are few studies available examining the associations between 
the age at which menopause occurs and physical function performance (57–59). Velez 
and Rosendaal et al. (57) assessed the age at natural menopause (ANM) and physical 
function in 775 older women (ages 65 to 74) who underwent natural menopause in 
Albania, Colombia, Brazil and Canada. ANM was self-reported as the age of the final 
menstrual period (FMP) and divided into 5 categories: <40, 40-44, 45-49, 50-54, and 
≥55 years. Handgrip strength and physical function (3-meter or 4-meter gait speed) 
were measured. When adjusting for age, years of education, income, height, BMI, 
hormone replacement therapy, postmenopausal hysterectomy, smoking status, and 
childhood economic and social adversity, with ANM 50-54 as the reference group, 
those with ANM ≥55 had a significantly higher gait speed  (p=0.005), but not a 
significantly different handgrip strength (p=0.493). Additionally, those with ANM <40 
had a significantly worse handgrip strength than those with ANM 50-54 (p=0.001).  
Velez and Alvarado et. al (58) similarly studied ANM and physical function in 
9,920 naturally postmenopausal women aged 45-85 at baseline, using the Canadian 




assessed, and analyses controlled for education, BMI, hormone replacement, smoking 
status, age, and study site. With ANM 50-54 as a reference, women with ANM <40 
had a significantly slower gait speed (p<0.001) and lower grip strength (p=0.042), 
while women with ANM ≥55 had a significantly faster gait speed (p=0.001) and a 
significantly higher grip strength (p<0.001).  
Finally, Tom et al. (59) assessed 1,765 women from the United States aged 
≥60 using cross-sectional data from National Health and Nutrition Examination 
Survey (NHANES) III (59). ANM was again self-reported as the age of the FMP, and 
divided into 4 categories: <45, 45-49, 50-54, and ≥55. Objective physical function 
measures included walking speed at a natural pace over 8 feet and time to complete 5 
chair stands. Subjective physical function limitation was defined as having self-
reported difficulties in three or more of the following: walking a quarter mile; walking 
up 10 steps; stooping, crouching, or kneeling; lifting and carrying up to 10 pounds; 
and standing up from an armless chair. After controlling for age, race/ethnicity, height, 
weight, education, smoking status, number of children, and use of estrogen therapy, 
higher ANM was associated with higher walking speed (p<0.01), while there were no 
significant associations between ANM and chair rise time (p=0.79) or ANM and self-
reported functional limitation (p =0.06). While the latter was not statistically 
significant, these results suggest that later ANM is associated with lower chances of 
self-reported functional limitation. 
Considering these studies together, some evidence supports a significant 
association between age at menopausal onset and objective measures of physical 




function performance in a variety of measures, most often gait speed) (57–59). 
However, this association that has not been thoroughly explored, and it would benefit 
from further analysis.  
Physical Activity: Relationships with Age  
 Physical activity (PA) can be defined as any movement produced by the body 
that results in a significant increase in caloric expenditure above resting levels (60). It 
is clear that with age, including across middle-age, physical activity tends to decline 
(21) and sedentary time tends to increase (10). This has negative implications for 
physical functioning, as it is well established that, in middle-aged and older women, 
worse physical function performance is associated with lower physical activity levels 
(8,10,11,16,20,22,27,61–63) and increased sedentary time (10).  
Physical Activity: Relationships with Menopausal Status 
Since physical function performance is associated with physical activity level 
in middle-aged women (10,61), it is important to discuss how physical activity levels 
might change during the menopausal transition. However, independent of age, the 
association between menopausal status and physical activity is poorly established 
(16,26,34). Bondarev et al. (16) explored this relationship in 903 Finnish women ages 
47-55, with menopausal status determined by combination of hormonal levels and the 
self-reported STRAW criteria. A self-report 7-point physical activity scale was 
subdivided into “low”, “moderate”, and “high” scores. This study found no significant 
association between physical activity level and menopausal status (p=0.227). 
However, a limitation of this study was that no confounding variables were identified 




Da Câmara et al. (26) also found no significant relationship between 
menopausal status and physical activity level in 389 middle-aged Brazilian women 
(40-65). Menopausal status was self-reported according to the STRAW criteria. 
Physical activity level was self-reported as the total time per week subjects walked for 
at least 10 minutes without stopping, with results dichotomized as being <90 minutes 
per week and ≥90 minutes per week. Sedentary time was assessed as self-reported 
time sitting per day and dichotomized into <4 hours per day and ≥4 hours per day. No 
significant associations were found between menopausal status and sedentary time 
(p=0.642) or physical activity (p=0.305). 
In contrast, Duval et al. (34) found a significant association between 
menopausal status and certain measures of physical activity when examining 102 
premenopausal middle-aged women followed for 5 years. Menopausal status was self-
reported and verified with FSH levels. Categories were defined as “premenopausal” 
(no changes in the menstrual cycle frequency), “menstrual transition” (irregular cycles 
with variable cycle length >7 days different from normal and/or 2 skipped cycles and 
an interval of 60 days of amenorrhea), or “postmenopausal” (FMP over 12 months 
ago, with FSH levels >30 IU/L). All subjects were verified to be premenopausal at 
baseline, and menopausal status was re-assessed at the 5-year follow-up. Physical 
activity level was assessed via accelerometer, which recorded daily energy 
expenditure from PA and time spent in sedentary and moderate PA. They found that 
time spent in moderate physical activity decreased over the menopausal transition until 
the onset of menopause, with the only significant year-to-year difference being that 




week than women at the year of their FMP (p<0.05). Additionally, time spent in 
sedentary physical activity increased across the menopausal transition throughout 
postmenopause, with the year before the FMP having significantly lower sedentary 
time than the year of the FMP, and the year after the FMP having significantly higher 
sedentary time than the year of the FMP (all p<0.05). No significant associations were 
found between menopausal status and daily energy expenditure from PA. The results 
found by Duval (34) contrast those found by Bondarev (16) and Da Câmara (26), 
possibly because the latter two studies did not control for covariates that may have 
muted any associations between menopausal status and physical activity. 
 A major problem with research in this area is that physical activity levels are 
self-reported in two of the three studies (16,26), which may lead to errors, as adults 
tend to overreport both time and intensity of exercise, with women providing a larger 
overestimation of their physical activity compared to men (64,65). Additional research 
is needed to support the accuracy of the one study relating menopausal status to 
accelerometer-measured physical activity (34), which the present study seeks to 
address. 
Body Composition: Relationships with Age and Menopausal Status 
 Body composition has an impact on many areas of health, including physical 
function performance, and aging is associated with changes in body composition (66). 
Increases in subcutaneous fat and visceral abdominal fat are seen with increased age in 
middle-aged women (22) and in women throughout the lifespan (23), while lean mass 




Poorer performance on physical function measures in middle-aged and older 
women is associated with higher adiposity (20), lower lean mass (20), lower leg 
mineral-free lean mass (MFLM) (67), higher body weight to MFLM ratio (67), higher 
visceral fat (22), poorer muscle quality (62), and increased relative adiposity (62). 
Thus, it is important to understand changes in body composition with menopausal 
status. Unlike physical activity and physical function, there is a large volume of 
research describing differences in body composition between menopausal status 
groups (31,42,43), although there is little agreement between studies. In the past 5 
years, two review articles have compiled the literature regarding this association 
(42,43). 
The first review article by Al-Safi et al. (42) described the associations 
between menopausal status and body composition and found that the associations 
between body mass and FMP are inconsistent. A number of studies reported that 
indirect estimates of poorer body composition such as higher BMI/weight gain were 
associated with later age at natural menopause (68), while other studies reported no 
significant associations (69). Furthermore, Al-Safi found that menopausal status is 
significantly associated with weight gain in four studies (32,33,36,37), but only two of 
these studies found this association to be significantly independent of age (33,37). 
When examining body composition with a highly valid direct measure (computed 
tomography, or CT), visceral and total body fat increased only throughout 
postmenopause, while subcutaneous adipose increased with age across menopausal 
stages, indicating that possible differences in fat distribution may occur along the 




were able to attribute a large amount of the weight gain across the menopausal 
transition to a reduction in energy expenditure seen during menopause, which is 
attributed to a combination of decreased physical activity and hormonal change 
associated with the menopausal transition (22). This underscores the importance of 
acknowledging the interactive relationships between body composition and lifestyle 
behaviors, including physical activity. 
Karvonen-Gutierrez et al. (43) provided a second review assessing the 
associations between menopausal status and body composition. This review also found 
evidence linking obesity to a later age at FMP, specifically when looking at studies 
using indirect measures of body composition. The majority of the cross-sectional 
studies analyzed found strong evidence for the association between a later FMP and 
better body composition via indirect measures such as BMI and weight (38). 
Conversely, most longitudinal studies found weak (39) to no (41) association using 
such measures; this may be due to inaccuracies in recalling BMI in longitudinal 
designs, or may suggest that this relationship is not strong. This review also provides 
more information looking at direct measurements of body composition, providing 
multiple studies using DXA (22,30), CT (30), and magnetic resonance imaging (MRI) 
(30) to reinforce the fact that women have relatively more subcutaneous abdominal fat 
prior to the FMP and relatively more visceral abdominal fat after the FMP, reflecting 
increased central body fat distribution. Further, this review reports multiple studies 
finding a significant association between later menopausal phase and decreased lean 




Greendale et al. (31) builds on these findings with a longitudinal assessment of 
1,246 premenopausal SWAN study participants with mean age 46.66 at baseline. Data 
was collected annually, with a mean of 10 visits and a maximum of 13. Menopausal 
status was self-reported according to the SWAN criteria, FMP was self-reported, 
weight was measured via scale, and body composition was measured via DXA 
(specifically reporting total fat mass and total lean mass). Fat mass and lean mass were 
found to both increase significantly prior to the start of menopause (1.0% per year 
with p<0.0001, and 0.2% per year with p=0.0002, respectively). At the start of 
menopause (approximately 2 years prior to the FMP), rate of fat gain doubled and 
significant lean mass loss occurred, with both of these trends decelerating 
approximately 1.5 years after the FMP but still continuing until 2 years after the FMP. 
Overall values for change during the menopausal transition are a 1.7% increase in total 
fat mass per year (p<0.0001) and a 0.2% loss in total lean pass per year (p=0.007). 
After the FMP, both fat mass gain and lean mass loss decelerated to a zero slope (i.e. 
no changes over time) (p≥0.1 for both). Contrastingly, weight and BMI increased 
linearly prior to and throughout the menopausal transition (0.3% and 0.4% per year 
respectively, both with p<0.0001), with accelerations approximately 1 year before the 
FMP, decelerations approximately 3 years after the FMP, and stability after 
menopause. This study underscores the potential oversimplification of using indirect 
measurements of body composition (such as weight or BMI) to assess changes during 
menopause and may provide some explanation of the conflicting results seen with the 




Despite there being a large volume of research on the relationship between 
menopausal status and body composition, it is still difficult to decipher to what degree 
the changes in body composition seen in middle-age women are primarily driven by 
menopause, aging, or other related lifestyle/behavioral factors. Based on present 
evidence, it seems that increases in weight (i.e. increases in BMI) seen during 
menopause may be more strongly associated with age than menopausal status, since 
BMI is associated with menopausal status (36), but rarely when age is controlled for 
(37). On the other hand, changes in fat distribution and lean mass (observed with 
direct measurements like DXA, CT, and MRI) may be more strongly associated with 
menopause, as increased visceral abdominal fat (22,30,31) and decreased lean mass 
(28,58,69) have been shown with advancing menopausal phase, even when controlling 
for age. A major limitation of the current research in this area is that the most common 
methods of describing body composition are indirect estimates (such as BMI and 
waist-to-hip-ratio) and not direct measurement techniques (such as DXA), which 
would likely produce more accurate and descriptive results and may change the 
observed trends. 
Conclusion: 
 Middle-aged women are understudied in general, and there is especially little 
agreement on the associations between menopausal status and physical function, 
physical activity, and body composition. From existing literature, there is preliminary 
evidence associating more advanced menopausal status with poorer physical function 
(16,24–29), lower physical activity (34), and poorer body composition 




 However, it is difficult to make conclusions about these associations because 
there is little commonality in measurement techniques in existing literature. Each 
variable has a number of options for measurement: menopausal status can be self-
reported by the SWAN, STRAW, or PENN-5 criteria, or measured with blood levels 
of hormones such as through the WISE criteria; physical function can use self-report 
measures like the SF-36 physical functioning subscale or objective tasks such as the 6-
minute walk test; physical activity can be self-reported with questionnaires or 
objectively measured via accelerometry; body composition can be estimated with 
indirect measurements such as BMI or directly measured with tools like DXA. Thus, it 
is possible that only certain measures of physical function, physical activity, and body 
composition are sensitive enough to detect significant differences between menopausal 
status groups, whereas others are not.  
Despite these difficulties, it is important to further investigate differences in 
physical function, physical activity, and body composition between menopausal status 
groups in order to better understand the health of women at all stages of the 
menopausal transition. Middle-age may offer an important time frame to improve or 
slow the progression of any negative changes in physical function, physical activity, 
and body composition before they tend to decline at a more rapid rate in older 
adulthood (6). Thus, a better understanding of any negative changes during middle-age 
may help to optimize prevention and treatment during this period of life, ideally 
leading to improved health in middle-age that continues into older adulthood.  
The present study clarifies and adds to existing literature by incorporating 




menopausal status (transfer task, 8-foot up-and-go, 30-second chair stand, and lift-and-
carry), as well as incorporating physical function measures that have been studied in 
association with menopausal status (6-minute walk test, handgrip strength, and the SF-
36 physical functioning subscale) to allow for comparison with existing literature. 
Further, it adds to the understanding of associations between menopausal status and 
accelerometer-measured physical activity and adds to the equivocal evidence base 









A convenience sample was recruited on a rolling basis from 2016 to 2019 via 
flyers posted at the University of Rhode Island and in the local community, social 
media posts, and word of mouth. Eligibility criteria required participants to be middle-
aged (40-64 yr), English-speaking women living independently, with BMI values 
below 45.0 kg/m2 (the capacity of the DXA scanner in this study). Subjects were 
excluded if they were currently smoking (or quit in the past 6 months), were pregnant, 
had any diseases or conditions preventing safe study participation, or experienced 
weight change of over five pounds in the past three months. Participants also had to be 
willing to wear an accelerometer for a seven to ten- day period and participate in a 
DXA scan. All study procedures were approved by the University’s Institutional 
Review Board (IRB) in October 2016 (board reference number HU1516-206) and all 
participants signed an IRB approved informed consent form prior to enrollment in the 
study. 
Procedures 
Interested participants completed an online eligibility survey to determine if 
they met basic inclusion criteria. If inclusion criteria were met, these individuals were 
contacted via email to schedule two visits to the Human Performance Laboratory at 




by seven to ten days. During the first visit, participants provided written informed 
consent, and completed the Physical Activity Readiness Questionnaire (PAR-Q) and 
the Mini-Mental State Exam. Additionally, self-reported menopausal status, 
chronological age, and muscular strength and physical function measures were 
assessed during visit 1. Participants were then provided with an accelerometer to wear 
for seven to ten days and were given a physical activity log.  
Visit 2 was conducted seven to ten days after visit 1, to allow for the collection 
of objectively measured physical activity data via accelerometry, medical history, and 
quality of life. During visit 2, accelerometers were returned, and physical activity logs 
were reviewed with participants for any necessary clarification. Further, DXA scans 
and measures of muscular capacity assessments were performed during visit 2.  
Menopausal Status Assessment 
Menopausal status was self-reported utilizing the SWAN criteria but combined 
postmenopausal stages (stages 3 and 4), as is the norm in much of present literature 
(5). The SWAN criteria is as follows: stage 1) pre-menopausal was defined as no 
change in menstrual bleeding patterns; stage 2) early transition/peri-menopause was 
defined as a change in length of bleeding or the interbleed interval; stage 3) late 
transition/peri-menopause was defined as no menstrual bleeding (amenorrhea) in the 
last 3-11 months; and stage 4) post-menopause, which was divided into natural post-
menopause, defined as no bleeding in the past 12 months not due to hysterectomy 
(surgical removal of the uterus), and surgical post-menopause, defined as a bilateral 





Chronological Age Assessment 
Birth date was self-reported and used to determine chronological age.  
Body Composition Assessment 
Weight in kg was obtained via a calibrated digital scale (Tanita WB-100, 
Arlington Heights, IL) and standing height in cm was obtained via a stadiometer (Seca 
213, Chino, CA). BMI was computed with the formula BMI = (weight in kg) / ([height 
in m]2). DXA scans were performed by a trained professional using a GE Lunar iDXA 
(Waukesha, WI). Fat mass (FM) and mineral-free lean mass (MFLM) were obtained 
according to manufacturer’s guidelines and converted into percentages. 
Physical Activity Assessment 
Physical activity level was measured via ActiGraph accelerometers (Actigraph 
GT9XLink, Pensacola, FL) between visits 1 and 2 (seven to ten days). Physical 
activity was quantified by average steps per day (steps/day), average minutes spent in 
moderate and vigorous physical activity per day (MVPA/day), and average minutes 
spent in low, moderate and vigorous activity per day (LMVPA/day). Physical activity 
logs were also completed by participants on the days they wore the accelerometer and 
compared to accelerometer data to ensure accuracy. To be included in the final data 
analysis, participants needed at least 4 valid wear days (a day with at least ten hours of 
confirmed wear). This data was analyzed via the accompanying ActiLife software.  
Objective Measures of Physical Function 
All objective physical function measures were performed by trained personnel 
following standardized scripts and using standardized equipment. At least two minutes 




complete a second trial of any functional tasks they chose if they thought they could 
improve upon their first trial. 
• Transfer task (TRANSFER): The participant began in a standing position on a 
mat. On the command “go”, the participant sat down on the mat and returned 
to a standing position in whatever manner they chose as quickly as possible. 
Total time was recorded (70). 
• 8-foot up-and-go (UPGO): The participant began seated in an armless chair 
with its back placed against a stable surface such as a wall. On the command 
“go”, the participant stood up and walked around a small plastic cone placed 8-
feet from the chair and returned to a seated position in the chair as quickly as 
possible. Total time was recorded (71). 
• 30-second chair stands (STAND): The participant began seated in an armless 
chair with its back placed against a stable surface such as a wall. On the 
command “go”, the participant rose to a standing position using only the legs, 
keeping her arms crossed across her chest. The participant proceeded to return 
to a fully seated (i.e. buttocks contacting the chair) position and then fully 
standing position as many times as possible in 30 seconds. Total number of full 
touches between buttock and chair was recorded (72). 
• 6-minute walk test (6MWT): The participant began in a standing position at 
the end of a preset course a known distance apart (30 feet). On the command 
“go”, the participant walked as quickly as possible, performing laps back and 
forth over the preset course in order to cover as much distance as possible in 6 




continue walking the entire time, but termination and/or rest breaks were 
allowed at any point. The total distance covered (the distance of each pass x 
the total number of passes + the distance of the final partial pass) was recorded 
(73). 
• Lift and carry (LIFT): The participant began in a standing position at the end 
of a preset 20-foot course. A milk crate was placed next to the participant 
containing 10 lbs. At the other end of the course, a shelf of standard height 
(51.5 inches tall) was placed against a wall. On the command “go”, the 
participant lifted the crate using proper lifting technique, walked over the shelf, 
placed the crate on the shelf, fully released her grip on it, picked the crate back 
up, returned to the starting position, put the crate down, and fully released her 
grip on it. The participant completed 5 repetitions of this sequence. Total time 
was recorded. 
• Lower extremity physical function composite score (LEPF-CS): Z scores for 
the four lower extremity physical function tasks (transfer task, 8-foot up-and-
go, 30-second chair stands, and 6-minute walk test) were computed using 
SPSS statistical analysis software. Z scores in which a lower score reflected 
better physical function (transfer task and 8-foot up-and-go) were reverse 
scored by taking the inverse of the Z score. Then, all four Z scores were totaled 
to form the lower extremity physical function composite score. 
Subjective Measure of Physical Function 
The RAND 36-Item Short Form Survey (SF-36) was used to measure health-




functioning subscale of the SF-36 (SF-36 PF). This subscale contains ten items that 
assess an individual’s perception of their ability to be physically active and complete 
activities of daily living on a 3-point Likert scale (yes, limited a lot; yes, limited a 
little; and no, not limited at all) (74,75). Previous literature has consistently found an 
association between menopausal status and this subscale (24,28,29), and thus it was 
included to compare the results of this study with previous literature on the topic. 
Muscular Strength Assessment  
Muscular strength was estimated via hand grip dynamometry (Jamar 
Technologies Hydraulic Hand Dynamometer, Bolingbrook, IL). Maximal handgrip 
strength was tested twice bilaterally according to manufacturer instructions. The 
average value for the right and left hands were computed and summed for an overall 
handgrip score (HGS). 
Statistical Analysis 
SPSS statistical software version 26.0 for Windows (IBM Corp, Armonk, NY) 
was utilized to perform all data analysis. All data was assessed for normal distribution; 
outliers in outcome variables (defined as data points falling outside of 3 standard 
deviations from the mean) were excluded from the study. Next, descriptive statistics 
were calculated for the total sample as well as for each menopausal group. A 
multivariate analysis of covariance (MANCOVA) and subsequent post hoc analysis 
were used to analyze differences among these groups, with age and total number of 
chronic medical conditions as control variables. Finally, linear multiple regression 













180 middle-aged women were screened for participation in this study. Eleven 
were deemed ineligible for reasons including, being a smoker (2), not living 
independently (1), BMI too large or not weight stable (7), or severe musculoskeletal 
disorder (1). Thirty-eight did not respond to follow-up contact, leaving 131 eligible 
participants. Four declined participation, therefore 127 scheduled visit 1. Four subjects 
chose not to attend and one did not complete visit 1 due to severe hypertension. Two 
declined scheduling visit 2 due to the time commitment, therefore 120 completed visit 
2. Thirteen subjects were excluded from data analysis because of missing data (10) or 
representing outliers 3 or more standard deviations outside of the mean on measures of 
physical function (3). Thus, 107 participants were included in the final data analysis. 
 Table 1 shows participant characteristics for the entire sample (n=107) and 
Table 2 shows participant characteristics by menopausal status group (premenopausal 
n=22, perimenopausal n=24, and postmenopausal n=61). The sample was 98.13% 
white. On average, participants had 3.04 ± 2.50 significant chronic conditions and 
regularly took 1.02 ± 1.30 prescription medications and 1.33 ± 2.20 over-the-counter 
medications. The sample was overweight (BMI of 25 to < 30 kg/m2) (60) with a mean 
BMI of 26.31 ± 5.11 kg/m2. Mean percent fat was 38.04 ± 8.06%, which fell into the 
“very poor” classification of percent fat using the American College of Sports 




≥34.9% for women 50-59) (60). However, the sample’s percent fat was lower than 
United States population norms (39.2% for women ages 40-49, 41.7% for women ages 
50-59, and 42.4% for women ages 60-69) (76).  
When assessing physical activity levels, 78.5% of the sample met the required 
four complete wear days (10 hours or more) for the accelerometer. Average wear time 
was 6.18 ± 1.06 complete days per person. Only 25.23% of participants met the 
recommended 10,000 steps per day (77) and 42.99% achieved an average of at least 
30 minutes of moderate to vigorous activity per day.  
 Figures 2a-2h display MANCOVA findings examining differences in body 
composition, physical activity level, and physical function between menopausal status 
groups. Controlling for age and total number of chronic medical conditions, no 
statistically significant differences between menopausal status groups were found for 
any of the outcome variables. As there were no significant between-group differences 
found in the MANCOVA, post hoc analysis was not performed. ANOVA found that 
age was significantly different between each menopausal status group (p≤0.001 for all 
comparisons). 
 Tables 3a and 3b provide results from multiple linear regression analysis 
assessing the independent associations of age and menopausal status with body 
composition, physical activity level, and measures of physical function when 
controlling for total number of chronic medical conditions. Age was independently 
associated with TRANSFER (p=0.015), explaining 11.1% of the variability in 
TRANSFER when chronic medical conditions were held constant. The overall model 




chronic medical conditions, was significant as well (p=0.001), although menopausal 
status was not independently associated with TRANSFER (p=0.876). Similarly, age 
was independent associated with HGS (p=0.002), explaining 14.7% of the variability 
in HGS when chronic medical conditions were held constant. The overall model was 
significant as well (p=0.001), although menopausal status was not a significant 
independent predictor of HGS (p=0.500). Menopausal status and age were not 
significant predictors of any other outcome variables, and no other models achieved 
overall significance (p<0.05).  
Tables 4a-4c report correlations between study variables for premenopausal, 
perimenopausal, and postmenopausal women when controlling for age, BMI, and total 
number of chronic medical conditions. Correlations between study variables vary 
greatly when comparing menopausal status groups. For example, the correlations 
between measures of body composition and physical activity is stronger for 
premenopausal women (Table 4a) and postmenopausal women (Table 4c) compared 
to perimenopausal women (Table 4b). Specifically, the correlation (r) between steps 
per day and fat mass % is -0.322 in premenopausal women, -0.121 in perimenopausal 
women, and -0.313 in postmenopausal women. Similarly, the correlation (r) between 
MVPA per day and fat mass % is -0.359 in premenopausal women, -0.191 in 
perimenopausal women, and -0.299 in postmenopausal women. Also of note is that the 
correlation between the lower extremity physical function composite score and body 
composition (percent fat) is stronger in premenopausal women (r=- 0.351) and 
postmenopausal women (r=-0.265) compared to perimenopausal women (r=0.039), 




Interestingly, which measure of physical activity is most strongly associated with 
the lower extremity physical function composite score varies by menopausal status; in 
premenopausal and postmenopausal women it is MVPA/day (r=0.421 and 0.361, 
respectively), while in perimenopausal women it is LMVPA/day (i.e. total PA per day; 
r=0.628). Relationships between individual measures of physical function and 
physical activity is also highly variable between menopausal status groups, with mean 
correlations between all measures of physical activity (steps/day, MVPA/day, and 
LMVPA/day) and all measures of physical function (transfer task time, 8-foot up-and-
go time, 30-second chair stand repetitions, 6-minute walk test distance, lower 
extremity physical function composite score, SF-36 physical functioning subscale, and 
handgrip strength) being close to 0 for all groups (r=0.108 for premenopausal, 0.042 
for perimenopausal, and -0.004 for postmenopausal). High variability in these results 
indicate that the associations between study variables vary with different phases of the 
menopausal transition, with perimenopausal women often exhibiting weaker 








The present study explores: (1) the differences in age, physical function 
performance, and physical activity among menopausal status groups, and (2) the 
strength of the associations between age, menopausal status, physical function 
performance, physical activity, and body composition in middle-aged women. Middle-
aged women are often underrepresented in research for a variety of reasons including 
hormonal fluctuations (5,16) and pregnancy (18,19). Therefore, this study builds on 
the understanding of these associations in an understudied population using both 
standard measures in the existing literature and measures of physical function that 
have not been previously tested in association with menopausal status. Further, this 
study seeks to describe differences in correlates of physical function between 
menopausal status groups that have been rarely (physical activity) or inconsistently 
(body composition) reported using the sophisticated measurement techniques of 
accelerometry and DXA 
The results of this study refute the primary hypothesis that there would be 
significant differences in physical function, physical activity, and body composition 
between menopausal status groups, as the only significant difference found between 
menopausal status groups was age. Similarly, the results of this study refute the 
secondary hypothesis. Overall, in contrast to what has been seen in previous studies 




chronic medical conditions, age, and menopausal status were generally poor predictors 
of physical function, physical activity, and body composition. Specifically, 
menopausal status was not significantly and independently associated with any 
measures of physical function, physical activity, or body composition when 
controlling for total number of chronic medical conditions. With the same control 
variables, age was significantly and independently associated with transfer task and 
handgrip strength performance.  
The null findings in this study may be a result of the fact that the study 
participants exhibited somewhat higher physical function, higher physical activity, and 
more optimal body composition compared to population norms and results from 
similar studies. Specifically, the present study’s participants reported higher mean SF-
36 physical functioning subscale scores (94.71) compared to a mean score of 85.3 
found in a study of 506 middle-aged women (24). Additionally, a study of 1,862 
middle-aged adults found a mean of 6,801 steps per day (78) compared to a mean of 
8,256 steps per day in this study and a study of 962 middle-aged women found a mean 
of 29.2 minutes of MVPA per day (79) compared to 32.2 minutes of MVPA per day in 
the present investigation. Furthermore, % fat was lower in this study (37.8%) 
compared to population norms for women in United States (39.2% for ages 40-49, 
41.7% for ages 50-59, and 42.4% for ages 60-69) (76). Thus, the present sample 
appears healthier in these variables compared to the general population of middle-aged 
women in the US, which may account for why the study results overall disagreed with 




This study’s findings that there are no associations between menopausal status 
and physical function conflict with much of the existing body of literature. Sowers and 
Tomey et al. (24) demonstrated that, when controlling for age, BMI, and smoking 
behavior, self-reported menopausal status was associated with the objective physical 
function measures of 3-stair ascent time, sit-to-stand time, and maximal gait velocity, 
as well as self-report perceived physical functioning using the SF-36. A possible 
reason why the present study’s findings conflict with those of Sowers and Tomey et al. 
(28) is that the two investigations used different measures of objective physical 
functioning; it is possible that some measures of objective physical functioning may 
be more sensitive to change during the menopausal transition. Furthermore, the study 
by Sowers and Tomey et al. (24) followed a 5-year longitudinal design and it is 
feasible that longitudinal designs are optimal for identifying changes across the 
menopausal transition, compared to a cross-sectional approach. Importantly, Sowers 
and Tomey et al. (24) also used their own definition of menopausal status stages, as 
opposed to the more established SWAN criteria, which may also impact their results. 
Also in contrast with the present findings, a cross-sectional study by Tseng et 
al. (28) and a longitudinal study by El Khoudary et al. (29) found significant 
associations between menopausal status and the SF-36 physical functioning subscale 
when controlling for age, with poorer self-perceived function in those who were 
further along in the menopausal transition. While these studies used the SWAN 
criteria for defining menopausal status, they both had a much larger sample size 




Larger sample sizes may help ensure the sample is more representative of the selected 
population.  
Previous work done in London and Brazil (25,26) found significant 
associations between menopausal status and the strength outcome of handgrip strength 
when controlling for age. Therefore, findings related to our outcomes of interest may 
be region/location specific and may only be generalizable to middle-aged women from 
these areas. Both of these studies also used alternative measurements of menopausal 
status to the SWAN criteria (25,26), which may have contributed to differences in 
results. Kurina et al. (27) also found that associations between menopausal status and 
grip strength in women in the United States were present but non-significant. This 
study used the SWAN criteria, although it was longitudinal, which may account for 
differences in results compared to the present study. 
While the majority of pre-existing literature shows association between 
menopausal status and physical function when controlling for age (24–27,29), several 
available studies agree with the results of the present investigation and have found no 
significant associations between these outcomes (25,26,28). For example, Tseng et al. 
(28) found that natural gait velocity was not significantly associated with menopausal 
status when controlling for age in women in the United States. Cooper et al. (25) 
found that 30-second single-leg stand time and repeated chair stand performance were 
not significantly associated with menopausal status when controlling for age. 
Additionally, Da Câmara et al. (26) found that natural gait velocity and repeated chair 
stands were not associated with menopausal status when controlling for age, in a 




second chair stand task. It is possible that there are no significant differences in 
physical function among menopausal status groups, but it is also possible that the 
objective measures of physical function utilized in these studies (25,26) and the 
present study are not sensitive enough to detect smaller differences in physical 
function that may exist between menopausal status groups. In regards to physical 
activity, the present results align with cross-sectional studies using self-report physical 
activity (16,26), but contrast with a longitudinal study using accelerometer-measured 
physical activity (34). It is possible that study design accounts for these conflicting 
results, as cross-sectional studies may be less representative of individuals’ true 
physical activity behaviors over time compared to longitudinal studies. The cross-
sectional nature of the present study may also be a limitation in that we are unable to 
make any conclusions about causality.  
 The present study’s findings that there are no associations between menopausal 
status and body composition when controlling for age agree with existing literature on 
BMI (33,37,42,43), but disagree with previous work examining body fat and lean 
mass (22,30,31,35,40). The majority existing studies support that weight gain (i.e. 
increased BMI) is not associated with menopausal status when controlling for age 
(33,37). In contrast, negative changes in body fat distribution (i.e. increases in visceral 
abdominal fat) (22,30,31) and decreased lean mass (31,35,40) have been consistently 
associated with menopausal status when controlling for age. In three studies assessing 
US women with the SWAN criteria, DXA measurements, and longitudinal designs, 
the menopausal transition was associated with increased visceral abdominal fat 




(49), and decreased skeletal muscle mass (35),when controlling for age. Two cross 
sectional studies using alternative methods to define menopausal status similarly 
found the menopausal transition to be associated with increased visceral abdominal fat 
(30) and decreased lean mass (40) when controlling for age.  
The present study did not demonstrate a between-group difference in physical 
activity, unlike a prior study (34). As physical activity has been shown to be 
associated with improved physical function and body composition in middle-aged 
women (11), it is possible that elevated physical activity levels in the present sample 
are responsible for combatting any adverse effects of age or menopausal status on 
physical function and body composition in the current cohort. Furthermore, the 
strength of the association between physical activity and other study variables, 
including percent fat and physical function outcomes, vary greatly between 
menopausal status groups, indicating that these relationships may vary in strength 
across the menopausal transition. Specifically, it appears that physical function 
measures are least associated with body composition and physical activity measures in 
perimenopausal women and most strongly associated with body composition and 
physical activity in premenopausal women, indicating that perhaps an unconsidered 
variable is responsible for variability in physical function in these groups. 
All studies have limitations. First, many of the variables in the present study 
are highly associated with each other. For example, in middle-aged women, physical 
function is associated with both physical activity and body composition (11), and body 
composition and physical activity are associated with each other (20,22,62,67). Age 




p≤0.001). Due to these interrelations, it is difficult to differentiate individual 
relationships. Furthermore, this study might be limited by the fact that it uses self-
report menopausal status as opposed to blood-draw hormonal determinants. Adding 
blood-draw hormonal levels would provide a method of validating self-report 
menopausal status and may also provide an explanation for mechanisms of any 
observed changes in physical function, physical activity, and body composition over 
the menopausal transition (5). Additionally, as with all studies, results of the present 
study are only generalizable to populations similar to the study sample: community-
dwelling, non-smoking women ages 40-64 who were free of orthopedic or other health 
conditions preventing safe study participation. Notably, 98.13 percent of this sample 
was Caucasian. It is also possible that the sample selected is not representative of the 
true population it was attempting to represent. This study was advertised as an 
opportunity for middle-aged women to learn more about their present physical activity 
levels, physical function, and body composition; it is therefore possible that women 
less interested in their physical health self-selected out of this study, whereas more 
active women were more interested in learning about these characteristics. A final 
potential limitation of this study is its relatively small sample size. Larger sample sizes 
may be more representative of the actual population of non-smoking middle-aged 
women, which might provide a more accurate picture of physical function and its 
correlates in this population.  
In conclusion, more research is still needed to help clarify the associations 
between age, menopausal status, physical function, physical activity, and body 




significant associations between age and two outcome measures: transfer task time and 
handgrip strength. It is possible that the true associations between age and menopausal 
status and the outcome measures of physical function, physical activity, and body 
composition are weak to nonexistent, and that other factors are responsible for 
variability in these outcome measures. However, it is also possible that the limitations 
in this study have prevented the observation of significant associations. Future studies 
would optimally be longitudinal in nature in order to monitor these variables over the 
menopausal transition. Other measures of physical function such as maximal gait 
velocity and 3-stair ascent time (24) should also be incorporated, as it is possible that 
some measures of physical function are more sensitive to change and therefore, more 
strongly associated with menopausal status than others. This research will help us 
better understand the causes and correlates of physical function in middle aged 
women. In turn, this understanding will help guide interventions to improve the 
physical function limitations observed in approximately one fifth of middle aged 
women (2,3), and could prevent the decline in physical functioning that accelerates 








Table 1. Participant demographics (n=107) 
Variable Mean ± SD Range 
Age (y) 53.31 ± 6.14 40-64 
Height (cm) 163.35 ± 5.51 150.60-177.60 
Weight (kg) 69.71 ± 14.48 44.30-118.30 
BMI (kg/m²) 26.09 ± 5.11 17.63-42.93 
FM (%) 37.77 ± 8.06 18.99-55.84 
MFLM (%) 62.23 ± 8.06 44.16-81.01 
Steps/day 8256.65 ± 3321.90 3275.40-20301.83 
MVPA/day (min) 32.16 ± 24.49 2.00-113.14 
LMVPA/day (min) 329.37 ± 75.65 170.00-609.00 
TRANSFER time (s) 3.81 ± 0.99 1.53-6.75 
UPGO time (s) 5.24 ± 0.85 2.38-7.37 
STAND repetitions (reps) 20.23 ± 5.35 10.00-38.00 
6MWT distance (m) 576.03 ± 67.49 429.30-734.31 
LIFT time (s) 57.99 ± 9.48 38.84-80.66 
LEPF-CS 0.10 ± 2.92  -5.99-8.34 
SF-36 PF 94.71 ± 7.66 65.00-100.00 
HGS (kg) 53.31 ± 12.53 18.00-90.00 
 
BMI = body mass index; FM = fat mass; MFLM = mineral-free lean mass; Steps/day 
= average number of steps per day; MVPA/day = average minutes of moderate + 
vigorous physical activity per day; LMVPA/day = average minutes of light + 
moderate + vigorous physical activity; TRANSFER = transfer task; UPGO = 8-foot 
up-and-go; STAND = 30-second chair stands; 6MWT = 6-minute walk test; LIFT = 
lift and carry; LEPF-CS = lower extremity physical function composite score; SF-36 










Table 3a. Multiple regression for body composition and physical activity 
Variables B SEB p β 95% CI R
2 
(a) BMI (R²=0.047, p=0.174) 
Medical Conditions 0.03 0.02 0.147 0.14 [-.01,0.8] 0.019a 
Age -0.02 0.01 0.139 -0.23 [-0.05,0.01] 0.043b 
Menopausal Status 0.07 0.11 0.542 0.09 [-0.15,0.28] 0.047c 
(b) Fat mass (R²=0.011, p=0.757) 
Medical Conditions 0.25 0.32 0.430 0.08 [-0.38,0.88] 0.006a 
Age -0.13 0.21 0.543 -0.10 [-0.53,0.28] 0.006b 
Menopausal Status 1.15 1.56 0.465 0.11 [-1.95,4.24] 0.011c 
(c) Mineral-free lean mass (R²=0.011, p=0.757) 
Medical Conditions -0.25 0.32 0.430 -0.08 [-0.88,0.38] 0.006a 
Age 0.13 0.21 0.543 0.10 [-0.28,0.53] 0.006b 
Menopausal Status -1.15 1.56 0.465 -0.11 [-4.24,1.95] 0.022c 
(d) Total steps per day (R²=0.033, p=0.322) 
Medical Conditions -117.81 129.03 0.363 -0.09 [-373.70,138.09] 0.007a 
Age 14.15 83.49 0.866 0.03 [-151.44,179.74] 0.025b 
Menopausal Status 576.22 636.36 0.367 0.14 [-685.85,1838.29] 0.033c 
(e) Moderate and vigorous PA per day (R²=0.049, p=0.157) 
Medical Conditions -1.67 0.94 0.079 -0.17 [-3.55,0.20] 0.019a 
Age -0.14 0.61 0.819 -0.04 [-1.35,1.07] 0.019b 
Menopausal Status 5.19 4.65 0.268 0.17 [-4.04,14.41] 0.021c 
(f) Light, moderate, and vigorous PA per day (R²=0.017, p=0.614) 
Medical Conditions -0.08 2.96 0.978 0.00 [-5.96,5.79] 0.000a 
Age 0.42 1.92 0.826 0.03 [-3.38,4.23] 0.013b 
Menopausal Status 9.66 14.61 0.510 0.10 [-19.31,38.64] 0.017c 
 
B = unstandardized regression coefficient; SEB = coefficients standard error; β = 
standardized regression coefficient 
* p≤0.05 
** p≤0.001 
a  value for a model using chronic medical conditions as an independent variable 
b value for a model using chronic medical conditions and age as independent variables 






B = unstandardized regression coefficient; SEB = coefficients standard error; β = 
standardized regression coefficient 
* p≤0.05 
** p≤0.001 
a  value for a model using chronic medical conditions as an independent variable 
b value for a model using chronic medical conditions and age as independent variables 
c value for a model using chronic medical conditions, age, and menopausal status as 
independent variables 
Table 3b. Multiple regression for physical function and strength  
Variables B SEB p β 95% CI R² 
(g) Transfer task time (R²=0.14, p=0.001**) 
Medical Conditions 0.06 0.04 0.126 0.14 [-0.02,0.13] 0.012a 
Age 0.06 0.02 0.015* 0.36 [0.01,0.10] 0.123b 
Menopausal Status -0.03 0.18 0.876 -0.02 [-0.38,0.33] 0.115c 
(h) 8-foot up-and-go time (R²=0.040, p=0.235) 
Medical Conditions 0.05 0.03 0.141 0.14 [-0.02,0.11] 0.012a 
Age 0.02 0.02 0.415 0.13 [-0.03,0.06] 0.022b 
Menopausal Status 0.02 0.16 0.919 0.02 [-0.31,0.34] 0.012c 
(i) 30-second chair stands (R²=0.030, p=0.363) 
Medical Conditions -0.17 0.21 0.422 -0.08 [[-0.58,0.25] 0.006a 
Age -0.14 0.14 0.298 -0.16 [-0.41,0.13] 0.03b 
Menopausal Status 0.06 1.03 0.953 0.01 [-1.98,2.10] 0.03c 
(j) 6-minute walk test distance (R²=0.022, p=0.512) 
Medical Conditions -3.91 2.64 0.141 -0.15 [-9.14,1.32] 0.21a 
Age -0.23 1.71 0.893 -0.02 [-3.61,3.15] 0.022b 
Menopausal Status -0.90 13.02 0.945 -0.01 [-26.72,24.92] 0.022c 
(k) Lift and carry time (R²=0.059, p=0.099) 
Medical Conditions 0.44 0.36 0.232 0.12 [-0.28,1.16] 0.014a 
Age 0.40 0.24 0.091 0.26 [-0.07,0.87] 0.058b 
Menopausal Status -0.79 1.80 0.662 -0.07 [-4.35,2.78] 0.059c 
(l) Lower extremity physical function composite score (R²=0.069, p=0.063) 
Medical Conditions -0.18 0.11 0.112 -0.15 [-0.40,0.04] 0.015a 
Age -0.11 0.07 0.150 -0.22 [-0.25,0.04] 0.051b 
Menopausal Status 0.05 0.55 0.932 0.01 [-1.05,1.14] 0.042c 
(m) SF-36 physical functioning subscale (R²=0.035, p=0.311) 
Medical Conditions -0.56 0.31 0.076 -0.18 [-1.17,0.06] 0.031a 
Age -0.02 0.19 0.912 -0.02 [-0.41,0.36] 0.034b 
Menopausal Status -0.47 1.47 0.749 -0.05 [-3.38,2.44] 0.035c 
(n) Handgrip strength (R²=0.157, p=0.001**) 
Medical Conditions 0.41 0.45 0.368 0.08 [-0.49,1.31] 0.006a 
Age -0.94 0.29 0.002* -0.46 [-1.52,-0.36] 0.153b 

























Figure 2a. Transfer task performance by menopausal status 








Figure 2b. 8-foot up-and-go performance by menopausal status 







Figure 2c. 30-second chair stands performance by menopausal status 








Figure 2d. 6-minute walk test performance by menopausal status 








Figure 2e. Lift and carry performance by menopausal status 









Figure 2f. Lower extremity physical function composite score by menopausal status 









Figure 2g. SF-36 physical functioning subscores by menopausal status 









Figure 2h. Handgrip strength sums by menopausal status 


















































































































































































1.  Painter P, Stewart A, Carey S. Physical functioning: Definitions, measurement, 
and expectations. Adv Ren Replace Ther. 1999;6(2):110–23.  
2.  Gardener EA, Huppert FA, Guralnik JM, Melzer D. Middle-aged and mobility-
limited: Prevalence of disability and symptom attributions in a national survey. J 
Gen Intern Med. 2006;21(10):1091–6.  
3.  Brown RT, Diaz-Ramirez LG, Boscardin WJ, Lee SJ, Steinman MA. Functional 
impairment and decline in middle age: A cohort study. Ann Intern Med. 
2017;167(11):761.  
4.  Hartmann Rasmussen LJ, Caspi A, Ambler A, Broadbent JM, Cohen HJ, 
d’Arbeloff T, et al. Association of neurocognitive and physical function with gait 
speed in midlife. JAMA Netw Open. 2019;2(10):e1913123.  
5.  El Khoudary SR, Greendale G, Crawford SL, Avis NE, Brooks MM, Thurston 
RC, et al. The menopause transition and womenʼs health at midlife: a progress 
report from the Study of Womenʼs Health Across the Nation (SWAN). 
Menopause. 2019;26(10):1213–27.  
6.  Lachman ME, Teshale S, Agrigoroaei S. Midlife as a pivotal period in the life 
course: balancing growth and decline at the crossroads of youth and old age. Int J 
Behav Dev. 2015;39(1):20–31.  
7.  Spoelstra SL, Sikorskii A, Gitlin LN, Schueller M, Kline M, Szanton SL. 
Dissemination of the CAPABLE model of care in a Medicaid waiver program to 
improve physical function. J Am Geriatr Soc. 2019;67(2):363–70.  
8.  Manini TM, Pahor M. Physical activity and maintaining physical function in 
older adults. Br J Sports Med. 2009;43(1):28–31.  
9.  Leigh L, Byles JE, Mishra GD. Change in physical function among women as 
they age: findings from the Australian Longitudinal Study on Women’s Health. 
Qual Life Res. 2017;26(4):981–91.  
10.  Spartano NL, Lyass A, Larson MG, Tran T, Andersson C, Blease SJ, et al. 
Objective physical activity and physical performance in middle-aged and older 
adults. Exp Gerontol. 2019;119:203–11.  
11.  Sternfeld B, Colvin A, Stewart A, Dugan S, Nackers L, El Khoudary SR, et al. 
The effect of a healthy lifestyle on future physical functioning in midlife women. 




12.  Zunzunegui MV, Alvarado BE, Guerra R, Gómez JF, Ylli A, Guralnik JM, et al. 
The mobility gap between older men and women: The embodiment of gender. 
Arch Gerontol Geriatr. 2015;61(2):140–8.  
13.  Whitson HE, Landerman LR, Newman AB, Fried LP, Pieper CF, Cohen HJ. 
Chronic medical conditions and the sex-based disparity in disability: The 
Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci. 
2010;65A(12):1325–31.  
14.  Mitnitski A, Song X, Rockwood K. Improvement and decline in health status 
from late middle age: Modeling age-related changes in deficit accumulation. Exp 
Gerontol. 2007;42(11):1109–15.  
15.  Burger HG, Hale GE, Robertson DM, Dennerstein L. A review of hormonal 
changes during the menopausal transition: focus on findings from the Melbourne 
Women’s Midlife Health Project. Hum Reprod Update. 2007;13(6):559–65.  
16.  Bondarev D, Laakkonen EK, Finni T, Kokko K, Kujala UM, Aukee P, et al. 
Physical performance in relation to menopause status and physical activity: 
Menopause. 2018;25(12):1432–41.  
17.  Costello JT, Bieuzen F, Bleakley CM. Where are all the female participants in 
sports and exercise medicine research? Eur J Sport Sci. 2014;14(8):847–51.  
18.  McCollough CH, Schueler BA, Atwell TD, Braun NN, Regner DM, Brown DL, 
et al. Radiation exposure and pregnancy: When should we be concerned? 
RadioGraphics. 2007;27(4):909–17.  
19.  Tendais I, Figueiredo B, Mota J, Conde A. Physical activity, health-related 
quality of life and depression during pregnancy. Cad Saúde Pública. 
2011;27(2):219–28.  
20.  Ward-Ritacco CL, Adrian AL, Johnson MA, Rogers LQ, Evans EM. Adiposity, 
physical activity, and muscle quality are independently related to physical 
function performance in middle-aged postmenopausal women. Menopause. 
2014;21(10):1114–21.  
21.  Watson KB, Carlson SA, Gunn JP, Galuska DA, O’Connor A, Greenlund KJ, et 
al. Physical inactivity among adults aged 50 years and older — United States, 
2014. MMWR Morb Mortal Wkly Rep. 2016;65(36):954–8.  
22.  Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral 
fat and decreased energy expenditure during the menopausal transition. Int J 
Obes. 2008;32(6):949–58.  
23.  Demerath EW, Rogers NL, Reed D, Lee M, Choh AC, Siervogel RM, et al. 




visceral adiposity in African-American and European-American women. Ann 
Hum Biol. 2011;38(3):247–56.  
24.  Sowers M, Tomey K, Jannausch M, Eyvazzadeh A, Nan B, Randolph J. Physical 
functioning and menopause states. Obstet Gynecol. 2007;110(6):1290–6.  
25.  Cooper R, Mishra G, Clennell S, Guralnik J, Kuh D. Menopausal status and 
physical performance in midlife: Findings from a British birth cohort study. 
Menopause. 2008;15(6):1079–85.  
26.  da Câmara SMA, Zunzunegui MV, Pirkle C, Moreira MA, Maciel ÁCC. 
Menopausal Status and physical performance in middle aged women: A cross-
sectional community-based study in northeast brazil. PLoS ONE. 
2015;10(3):e0119480.  
27.  Kurina LM, Gulati M, Everson-Rose S, Chung P, Karavolos K, Cohen N, et al. 
The effect of menopause on grip and pinch strength: Results from the Chicago, 
Illinois, site of the Study of Women’s Health Across the Nation. Am J 
Epidemiol. 2004;160(5):484–91.  
28.  Tseng LA, El Khoudary SR, Young EA, Farhat GN, Sowers M, Sutton-Tyrrell 
K, et al. The association of menopause status with physical function: the Study of 
Women’s Health Across the Nation. Menopause. 2012;19(11):1186–92.  
29.  El Khoudary SR, McClure CK, VoPham T, Karvonen-Gutierrez CA, Sternfeld B, 
Cauley JA, et al. Longitudinal assessment of the menopausal transition, 
endogenous sex hormones, and perception of physical functioning: The Study of 
Women’s Health Across the Nation. J Gerontol A Biol Sci Med Sci. 
2014;69(8):1011–7.  
30.  Toth MJ, Tchernof A, Sites CK, Poehlman ET. Menopause-related changes in 
body fat distribution. ann NY Acad Sci. 2006;904(1):502–6.  
31.  Greendale GA, Sternfeld B, Huang M, Han W, Karvonen-Gutierrez C, Ruppert 
K, et al. Changes in body composition and weight during the menopause 
transition. JCI Insight. 2019;4(5):e124865.  
32.  Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga PL. Weight gain at 
the time of menopause. Arch Intern Med. 1991;151(1):97–102.  
33.  Pasquali R, Casimirri F, Labate A, Tortelli O, Pascal G, Gatto M, et al. Body 
weight, fat distribution and the menopausal status in women. Int J Obes Relat 
Metab Disord. 1994;18(9):614–21.  
34.  Duval K, Prud’homme D, Rabasa-Lhoret R, Strychar I, Brochu M, Lavoie J-M, 
et al. Effects of the menopausal transition on energy expenditure: A MONET 




35.  Sowers M, Zheng H, Tomey K, Karvonen-Gutierrez C, Jannausch M, Li X, et al. 
Changes in body composition in women over six years at midlife: Ovarian and 
chronological aging. J Clin Endocrinol Metab. 2007;92(3):895–901.  
36.  Derby CA, Crawford SL, Pasternak RC, Sowers M, Sternfeld B, Matthews KA. 
Lipid changes during the menopause transition in relation to age and weight: The 
Study of Women’s Health Across the Nation. Am J Epidemiol. 
2009;169(11):1352–61.  
37.  Matthews K, Abrams B, Crawford S, Miles T, Neer R, Powell L, et al. Body 
mass index in mid-life women: Relative influence of menopause, hormone use, 
and ethnicity. Int J Obes. 2001;25:863–73.  
38.  DeLillis Henderson K, Bernstein L, Henderson B, Kolonel L, Pike MC. 
Predictors of the timing of natural menopause in the multiethnic cohort study. 
Am J Epidemiol. 2008;167(11):1287–94.  
39.  Trikudanathan S, Pedley A, Massaro JM, Hoffmann U, Seely EW, Murabito JM, 
et al. Association of female reproductive factors with body composition: The 
Framingham Heart Study. J Clin Endocrinol Metab. 2013;98(1):236–44.  
40.  Jaff NG, Norris SA, Snyman T, Toman M, Crowther NJ. Body composition in 
the Study of Women Entering and in Endocrine Transition (SWEET): A 
perspective of African women who have a high prevalence of obesity and HIV 
infection. Metabolism. 2015;64(9):1031–41.  
41.  Gold EB, Crawford SL, Avis NE, Crandall CJ, Matthews KA, Waetjen LE, et al. 
Factors related to age at natural menopause: Longitudinal analyses from SWAN. 
Am J Epidemiol. 2013;178(1):70–83.  
42.  Al-Safi ZA, Polotsky AJ. Obesity and menopause. Best Pract Res Clin Obstet 
Gynaecol. 2015;29(4):548–53.  
43.  Karvonen-Gutierrez C, Kim C. Association of mid-life changes in body size, 
body composition and obesity status with the menopausal transition. Healthcare. 
2016;4(3):E42.  
44.  Randolph JF, Zheng H, Sowers MR, Crandall C, Crawford S, Gold EB, et al. 
Change in follicle-stimulating hormone and estradiol across the menopausal 
transition: Effect of age at the final menstrual period. J Clin Endocrinol Metab. 
2011;96(3):746–54.  
45.  Paramsothy P, Harlow SD, Elliott MR, Yosef M, Lisabeth LD, Greendale GA, et 
al. Influence of race/ethnicity, body mass index, and proximity of menopause on 
menstrual cycle patterns in the menopausal transition: The Study of Women’s 




46.  Ramezani Tehrani F, Bahri M, Gholami R, Hashemi S, Bs KN. Secular trend of 
menopausal age and related factors among Tehrani women born from 1930 to 
1960; Tehran Lipid and Glucose Study. Arch Iran med. 2014;17(6):406–10.  
47.  Pakarinen M, Raitanen J, Kaaja R, Luoto R. Secular trend in the menopausal age 
in Finland 1997–2007 and correlation with socioeconomic, reproductive and 
lifestyle factors. Maturitas. 2010;66(4):417–22.  
48.  Avis NE, Colvin A, Bromberger JT, Hess R, Matthews KA, Ory M, et al. Change 
in health-related quality of life over the menopausal transition in a multiethnic 
cohort of middle-aged women: Study of Women’s Health Across the Nation 
(SWAN). Menopause. 2009;16(5):860–9.  
49.  Gold EB, Colvin A, Avis N, Bromberger J, Greendale GA, Powell L, et al. 
Longitudinal analysis of the association between vasomotor symptoms and 
race/ethnicity across the menopausal transition: study of women’s health across 
the nation. Am J Public Health. 2006;96(7):1226–35.  
50.  Namazi M, Sadeghi R, Behboodi Moghadam Z. Social determinants of health in 
menopause: An integrative review. Int J Womens Health. 2019;11:637–47.  
51.  Soules MR, Rebar R, Woods N. Executive summary: Stages of Reproductive 
Aging Workshop (STRAW). Fert Steril. 2001;76(5):5.  
52.  Gracia CR, Sammel MD, Freeman EW, Lin H, Langan E, Kapoor S, et al. 
Defining menopause status: Creation of a new definition to identify the early 
changes of the menopausal transition. Menopause. 2005;12(2):128–35.  
53.  Johnson BD, Bairey Merz CN, Braunstein GD, Berga SL, Bittner V, Keta 
Hodgson T, et al. Determination of menopausal status in women: The NHLBI-
sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study. J Women’s 
Health. 2004;13(8):872–87.  
54.  Johnston JM, Colvin A, Johnson BD, Santoro N, Harlow SD, Merz CNB, et al. 
Comparison of SWAN and WISE menopausal status classification algorithms. J 
Women’s Health. 2006;15(10):1184–94.  
55.  Brady AO, Straight CR, Evans EM. Body composition, muscle capacity, and 
physical function in older adults: An integrated conceptual model. J Aging Phys 
Act. 2014;22(3):441–52.  
56.  Collard RM, Boter H, Schoevers RA, Voshaar RCO. Prevalence of Frailty in 
Community-Dwelling Older Persons: A Systematic Review. Journal of the 
American Geriatrics Society. 2012;60(8):1487–92.  
57.  Velez MP, Rosendaal N, Alvarado B, da Câmara S, Belanger E, Pirkle C. Age at 
natural menopause and physical function in older women from Albania, Brazil, 




58.  Velez MP, Alvarado BE, Rosendaal N, da Câmara SM, Belanger E, Richardson 
H, et al. Age at natural menopause and physical functioning in postmenopausal 
women: the Canadian Longitudinal Study on Aging. Menopause. 
2019;26(9):958–65.  
59.  Tom SE, Cooper R, Patel KV, Guralnik JM. Menopausal characteristics and 
physical functioning in older adulthood in the National Health and Nutrition 
Examination Survey III: Menopause. 2013;19(3):283–9.  
60.  Riebe D. ACSM’s Guidelines for Exercise Testing and Prescription. 10th ed. 
Philidelphia, PA: Wolters Kluwer; 2018. 1 p.  
61.  Pettee Gabriel K, Sternfeld B, Colvin A, Stewart A, Strotmeyer ES, Cauley JA, 
et al. Physical activity trajectories during midlife and subsequent risk of physical 
functioning decline in late mid-life: The Study of Women’s Health Across the 
Nation (SWAN). Prev Med. 2017;105:287–94.  
62.  Straight CR, Brady AO, Evans EM. Muscle quality and relative adiposity are the 
strongest predictors of lower-extremity physical function in older women. 
Maturitas. 2015;80(1):95–9.  
63.  Paterson DH, Warburton DE. Physical activity and functional limitations in older 
adults: A systematic review related to Canada’s Physical Activity Guidelines. Int 
J Behav Nutr Phys Act. 2010;7(38):22.  
64.  Prince SA, Adamo KB, Hamel M, Hardt J, Connor Gorber S, Tremblay M. A 
comparison of direct versus self-report measures for assessing physical activity 
in adults: a systematic review. Int J Behav Nutr Phys Act. 2008;5(1):56.  
65.  Cerin E, Cain KL, Oyeyemi AL, Owen N, Conway TL, Cochrane T, et al. 
Correlates of agreement between accelerometry and self-reported physical 
activity. Med Sci Sports Exerc. 2016;48(6):1075–84.  
66.  JafariNasabian P, Inglis JE, Reilly W, Kelly OJ, Ilich JZ. Aging human body: 
changes in bone, muscle and body fat with consequent changes in nutrient intake. 
J Endocrinol. 2017;234(1):R37–51.  
67.  Valentine RJ, Misic MM, Rosengren KS, Woods JA, Evans EM. Sex impacts the 
relation between body composition and physical function in older adults: 
Menopause. 2009;16(3):518–23.  
68.  Reynolds RF, Obermeyer CM. Age at natural menopause in Spain and the United 
States: Results from the DAMES project. Am J Hum Biol. 2005;17(3):331–40.  
69.  Gold EB, Sternfeld B, Kelsey JL, Brown C, Mouton C, Reame N, et al. Relation 
of demographic and lifestyle factors to symptoms in a multi-racial/ethnic 




70.  Ng S, Fong S, Chan C, Fung F, Pang P, Tsang N, et al. Floor transfer test for 
assessing people with chronic stroke. J Rehabil Med. 2015;47(6):489–94.  
71.  Rose DJ, Jones CJ, Lucchese N. Predicting the probability of falls in community-
residing older adults using the 8-Foot Up-and-Go: A new measure of functional 
mobility. J Aging Phys Act. 2002;10(4):466–75.  
72.  Rikli RE, Jones J. Development and validation of a functional fitness test for 
community-residing older adults. J Aging Phys Act. 1999;7:129–61.  
73.  ATS Statement: guidelines for the six-minute walk test. Am J Respir Crit Care 
Med. 2002;166(1):111–7.  
74.  Ware JE, Donald Sherbourne C. The MOS 36-Item Short-Form Health Survey 
(SF-36): I. Conceptual framework and item selection. Med Care. 
1992;30(6):473–83.  
75.  White DK, Wilson JC, Keysor JJ. Measures of adult general functional status. 
Arthritis Care Res. 2011;63(S11):S297–307.  
76.  Imboden MT, Welch WA, Swartz AM, Montoye AHK, Finch HW, Harber MP, 
et al. Reference standards for body fat measures using GE dual energy x-ray 
absorptiometry in Caucasian adults. PLoS One. 2017;12(4):e0175110.  
77.  Tudor-Locke C, Craig CL, Brown WJ, Clemes SA, De Cocker K, Giles-Corti B, 
et al. How many steps/day are enough? for adults. Int J Behav Nutr Phys Act. 
2011;8:79.  
78.  Spartano NL, Demissie S, Himali JJ, Dukes KA, Murabito JM, Vasan RS, et al. 
Accelerometer‐determined physical activity and cognitive function in 
middle‐aged and older adults from two generations of the Framingham Heart 
Study. Alzheimers Dementia (N Y). 2019;5(1):618–26.  
79.  Pettee Gabriel K, Sidney S, Jacobs DR, Whitaker KM, Carnethon MR, Lewis 
CE, et al. Ten-year changes in accelerometer-based physical activity and 
sedentary time during midlife. Am J Epidemiol. 2018;187(10):2145–50.  
 
